Keykhosravi, S.; Rietveld, I.B.; Couto, D.; Tamarit, J.L.; Barrio, M.; Céolin, R.; Moussa, F.
[60]Fullerene for Medicinal Purposes, A Purity Criterion towards Regulatory Considerations. Materials 2019, 12, 2571.
https://doi.org/10.3390/ma12162571
AMA Style
Keykhosravi S, Rietveld IB, Couto D, Tamarit JL, Barrio M, Céolin R, Moussa F.
[60]Fullerene for Medicinal Purposes, A Purity Criterion towards Regulatory Considerations. Materials. 2019; 12(16):2571.
https://doi.org/10.3390/ma12162571
Chicago/Turabian Style
Keykhosravi, Sanaz, Ivo B. Rietveld, Diana Couto, Josep Lluis Tamarit, Maria Barrio, René Céolin, and Fathi Moussa.
2019. "[60]Fullerene for Medicinal Purposes, A Purity Criterion towards Regulatory Considerations" Materials 12, no. 16: 2571.
https://doi.org/10.3390/ma12162571
APA Style
Keykhosravi, S., Rietveld, I. B., Couto, D., Tamarit, J. L., Barrio, M., Céolin, R., & Moussa, F.
(2019). [60]Fullerene for Medicinal Purposes, A Purity Criterion towards Regulatory Considerations. Materials, 12(16), 2571.
https://doi.org/10.3390/ma12162571